-->

About us

The FLCCC Physicians

How the FLCCC Alliance came together and developed effective treatment protocols for COVID-19 (March 10, 2021)

This is the story about how the FLCCC Alliance was formed—and how, at the start of the pandemic, the team quickly began to develop protocols to successfully treat patients. Their first protocol was the MATH+ Hospital Treatment Protocol that was used to save critically ill patients and to prevent them from having to rely on ventilators to breathe.

Subsequently, as COVID-19 cases surged, they urgently researched ways to offload the hospitals and reduce case counts and deaths. The team developed the I-MASK+ Prevention & Early Outpatient Treatment Protocol—centered around the drug ivermectin—which is effective for every phase of COVID-19 disease… from prevention through late phase illness.

The Front Line Covid-19 Critical Care Alliance was created by highly published critical care specialists from major academic medical centers with collectively over 1,000 medical publications. Based on the rapidly emerging research into COVID-19, the early clinical experience in China reflected by the Shanghai expert commission, and their decades-long clinical and research experiences in severe infectious diseases around the country, the 5 experts developed the  MATH+ Hospital Treatment Protocol for Covid-19. It is intended for use early in the hospitalization of patients presenting with states of respiratory distress requiring supplemental oxygen. In October 2020, after reviewing numerous new studies from around the world on the antiparasitic drug ivermectin’s use in prophyaxis and all stages of treatment for COVID-19, the team created the  I-MASK+ protocol for prevention and early outpatient treatment. These 5 physicians have since been joined by an increasing number of hospitalist and ICU physicians who recognize the sound physiologic rationale, the emerging published research in support of the components, and the data demonstrating good clinical outcomes in hospitals and communities that have adopted the treatment regimen.

Founding members / MATH+ and I-MASK+ developers

Paul E. Marik

Paul E. Marik, M.D., FCCM, FCCP

Gianfranco Umberto Meduri

G. Umberto Meduri, M.D.

Joseph Varon

Joseph Varon, M.D., FCCP, FCCM

Jose Iglesias

Jose Iglesias, D.O.

  • Assoc. Prof., Hackensack Meridian School of Medicine at Seton Hall
  • Dept. of Nephrology & Critical Care / Community Medical Center
  • Dept. of Nephrology, Jersey Shore University Medical Center
  • Neptune, New Jersey
  • Curriculum Vitae – Dr. Jose Iglesias

Founding members

Clinical advisors

Eivind H. Vinjevoll

Eivind H. Vinjevoll, M.D.

  • Senior Consultant Anesthesiologist
  • Intensive Care, Emergency Medicine, Anesthesia
  • Volda, Norway
Scott Mitchell

Scott Mitchell, MBChB

  • Associate Specialist
  • Emergency Department
  • Princess Elizabeth Hospital
  • States of Guernsey
Dr. Eric Osgood

Eric Osgood, M.D.

  • Medical Director
  • Mission Hospitalists
  • St. Francis Medical Center, Trenton, NJ